Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2004, p. 2489-2494, Vol. 42, No. 6
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.6.2489-2494.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Division of Laboratory Research and Development, Center for Disease Control, Department of Health,1 Co-wealth Medical Science and Biotechnology, Taipei,3 Department of Emergency Medicine, Medical Center, Tzu Chi College of Medicine, Hualien, Taiwan, Republic of China2
Received 12 January 2004/ Returned for modification 7 February 2004/ Accepted 29 February 2004
Envelope and membrane (E/M) and nonstructural protein NS1 serotype-specific capture Immunoglobulin M (IgM) enzyme-linked immunosorbent assays (ELISAs) were developed to differentiate four dengue virus serotypes. A total of 93 anti-dengue virus IgM-positive serum samples collected between days 5 and 45 of illness from 59 confirmed dengue patients were analyzed. The results showed that positive serotype specificity could be identified for 86.1 and 47.6% of serum samples tested for E/M-specific IgM antibodies versus 83.3 and 42.9% of serum samples tested for NS1-specific IgM antibodies from patients with primary and secondary dengue virus infections, respectively. Dual analyses with both E/M and NS1 serotype-specific capture IgM ELISAs showed that positive serotype specificity could be correctly identified for 98.6 and 61.9% of all of the primary and secondary serum samples tested, respectively. These findings suggested that E/M and NS1 serotype-specific capture IgM ELISAs have the potential to be of use in dengue virus serotyping.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|